Effects of PCA2 and metabolites 4-HPAA on intracellular cholesterol accumulation a(units: mg g−1 protein).
| Groups | TC | FC | CE | CE/TC (%) |
|---|---|---|---|---|
| Control | 59.52 ± 6.17d | 41.05 ± 1.62c | 18.46 ± 7.52d | 31.02 ± 10.14d |
| ox-LDL | 138.97 ± 13.70a | 62.95 ± 1.14a | 76.03 ± 13.21a | 54.70 ± 4.09a |
| ox-LDL + 6.25 μg mL−1 PCA2 | 112.33 ± 2.39b | 55.51 ± 2.50b | 56.79 ± 3.25b | 47.51 ± 2.10ab |
| ox-LDL + 12.5 μg mL−1 PCA2 | 95.39 ± 1.63c | 55.54 ± 1.80b | 39.88 ± 0.95c | 41.77 ± 1.67c |
| ox-LDL + 6.25 μg mL−1 HPPA | 114.11 ± 1.56b | 56.56 ± 1.46b | 55.31 ± 2.68b | 48.47 ± 1.83ab |
| ox-LDL + 12.5 μg mL−1 HPPA | 99.02 ± 2.84c | 58.80 ± 1.58b | 42.46 ± 4.11c | 42.87 ± 2.94bc |
a
Values are expressed as mean ± SD. Values in the same column with different superscripts are significantly different at P < 0.05 level